Deskripsi
Visceral sensitivity measurements comparing berberine-treated and control rats are presented, showing colorectal distension response thresholds as indicators of pain sensitivity modulation.
Figure 2
ChartSource Paper
Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.Cite This Figure
![Figure 2: Visceral sensitivity measurements comparing berberine-treated and control rats are presented, showing colorectal distension response thresholds as indicators of pain sensitivity modulation.]() > Source: Jin-Dong Zhang et al. "Berberine alleviates visceral hypersensitivity in rats by altering gut microbiom." *Acta pharmacologica Sinica*, 2021. PMID: [33558654](https://pubmed.ncbi.nlm.nih.gov/33558654/)
<figure> <img src="" alt="Visceral sensitivity measurements comparing berberine-treated and control rats are presented, showing colorectal distension response thresholds as indicators of pain sensitivity modulation." /> <figcaption>Figure 2. Visceral sensitivity measurements comparing berberine-treated and control rats are presented, showing colorectal distension response thresholds as indicators of pain sensitivity modulation.<br> Source: Jin-Dong Zhang et al. "Berberine alleviates visceral hypersensitivity in rats by altering gut microbiom." <em>Acta pharmacologica Sinica</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33558654/">33558654</a></figcaption> </figure>